| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |